PDK1-IN-2 is a small-molecule inhibitor of 3-phosphoinositide-dependent protein kinase-1 (PDK1), used in research on cancer cell survival and proliferation by competitively binding to the PDK1 PIF pocket, thereby blocking PDK1-substrate interaction, inhibiting PDK1 kinase activity, and suppressing downstream signaling.